Kura Oncology Inc (KURA)
10.06
-5.85
(-36.77%)
USD |
NASDAQ |
Nov 21, 16:00
10.25
+0.19
(+1.89%)
Pre-Market: 08:18
Kura Oncology Total Assets (Quarterly): 478.84M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 478.84M |
| June 30, 2024 | 515.12M |
| March 31, 2024 | 553.91M |
| December 31, 2023 | 448.94M |
| September 30, 2023 | 473.77M |
| June 30, 2023 | 494.74M |
| March 31, 2023 | 425.98M |
| December 31, 2022 | 456.31M |
| September 30, 2022 | 447.99M |
| June 30, 2022 | 471.42M |
| March 31, 2022 | 498.58M |
| December 31, 2021 | 534.05M |
| September 30, 2021 | 561.14M |
| June 30, 2021 | 584.89M |
| March 31, 2021 | 620.26M |
| December 31, 2020 | 647.21M |
| September 30, 2020 | 339.57M |
| June 30, 2020 | 353.00M |
| March 31, 2020 | 226.46M |
| Date | Value |
|---|---|
| December 31, 2019 | 241.97M |
| September 30, 2019 | 254.60M |
| June 30, 2019 | 265.68M |
| March 31, 2019 | 169.62M |
| December 31, 2018 | 182.38M |
| September 30, 2018 | 191.50M |
| June 30, 2018 | 129.63M |
| March 31, 2018 | 141.46M |
| December 31, 2017 | 95.85M |
| September 30, 2017 | 103.12M |
| June 30, 2017 | 55.85M |
| March 31, 2017 | 61.92M |
| December 31, 2016 | 69.82M |
| September 30, 2016 | 76.30M |
| June 30, 2016 | 81.74M |
| March 31, 2016 | 80.38M |
| December 31, 2015 | 87.26M |
| September 30, 2015 | 42.83M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
226.46M
Minimum
Mar 2020
647.21M
Maximum
Dec 2020
468.71M
Average
476.30M
Median
Total Assets (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 13.59M |
| Perspective Therapeutics Inc | 391.15M |
| Protalix BioTherapeutics Inc | 61.56M |
| Electromed Inc | 48.92M |
| Armata Pharmaceuticals Inc | 98.24M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 55.07M |
| Shareholders Equity (Quarterly) | 423.77M |